Bortezomib Zentiva 1.0 mg, Lyophilisat zur Herstellung einer Injektionslösung - Swissmedic Key 68344001 Registration Holder Helvepharm AG Name Bortezomib Zentiva 1.0 mg, Lyophilisat zur Herstellung einer Injektionslösung Date of registration 05.08.2021 Original/Generic Generic Introduction of Sequence 05.08.2021 ATC-Classification Bortezomib (L01XG01) Revision date WHO WHO-DDD Valid until 04.08.2026 Index Therapeuticus (BSV) 07.16.10. Show package size Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 126.04 Limitation Yes Limitation text
Deductible 10 % Consumer price 153.50 Feedback FB GTIN 7680683440015 Medication Code Synthetika Pharmacode Disponibility
Composition bortezomibum 1 mg, mannitolum, pro vitro. Packungsbestandteile Galenic Form Lyophilisat Excipiens Active Agent Dose Bortezomibum 1 mg
BAG: Active Agent Dose Bortezomibum 1 mg
Inactive agents Mannitolum
Source Data was imported : 07.06.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
